Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionFulcrum Capital LLC
Latest Disclosed Ownership137,336 shares
Latest Disclosed Value $ 10,997,867
Fulcrum Capital LLC reports 0.08% increase in ownership of EW / Edwards Lifesciences Corporation

On April 30, 2026 - Fulcrum Capital LLC filed a 13F-HR form disclosing ownership of 137,336 shares of Edwards Lifesciences Corporation (MX:EW) valued at $10,997,867 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 137,220 shares of Edwards Lifesciences Corporation. This represents a change in shares of 0.08% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 137,336 116 0.08 10,998 -5.99 2.3875
2026-01-15 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 137,220 3,352 2.50 11,698 12.37 2.3492
2025-10-28 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 133,868 2,759 2.10 10,411 1.52 2.1346
2025-07-24 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 131,109 4,842 3.83 10,254 12.05 2.1689
2025-04-08 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 126,267 4,255 3.49 9,152 1.32 2.0289
2025-01-13 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 122,012 4,107 3.48 9,033 16.09 1.8914
2024-10-22 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 117,905 4,067 3.57 7,781 -26.01 1.6947
2024-07-22 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 113,838 267 0.24 10,515 -3.11 2.3942
2024-04-17 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 113,571 479 0.42 10,853 25.85 2.5756
2024-01-10 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 113,092 19,096 20.32 8,623 32.42 2.2299
2023-10-13 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 93,996 322 0.34 6,512 -26.30 1.8903
2023-07-27 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 93,674 -3,069 -3.17 8,836 10.41 2.3238
2023-05-11 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 96,743 7,034 7.84 8,004 19.57 2.1545
2023-01-24 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 89,709 6,439 7.73 6,693 -2.73 1.9342
2022-10-17 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 83,270 -2,487 -2.90 6,881 -15.62 2.0438
2022-08-03 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 85,757 -438 -0.51 8,155 -26.97 2.5632
2022-01-25 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 86,195 1,039 1.22 11,167 15.83 2.4215
2021-10-21 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 85,156 106 0.12 9,641 9.44 2.3065
2021-07-30 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 85,050 2,300 2.78 8,809 27.28 2.2101
2021-04-12 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 82,750 3,454 4.36 6,921 -4.33 1.9848
2021-02-09 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 79,296 3,749 4.96 7,234 19.97 2.1637
2020-10-21 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 75,547 -6,776 -8.23 6,030 5.99 2.1810
2020-07-27 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 82,323 53,395 184.58 5,689 4.27 2.1560
2020-05-01 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 28,928 110 0.38 5,456 -18.85 2.4767
2020-02-03 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 28,818 74 0.26 6,723 6.36 2.0818
2019-11-01 2019-09-30 13F/A-1 Edwards Lifesciences COM 28176E108 28,744 -27 -0.09 6,321 18.93 2.1586
2019-10-31 2019-09-30 13F Edwards Lifesciences COM 28176E108 28,744 -27 7,690 2.6968
2019-07-29 2019-06-30 13F Edwards Lifesciences COM 28176E108 28,771 6,262 27.82 5,315 23.40 1.9457
2019-05-08 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 22,509 665 3.04 4,307 28.72 1.6265
2019-02-12 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 21,844 1,310 6.38 3,346 -6.41 1.5077
2018-11-05 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 20,534 476 2.37 3,575 22.43 1.3939
2018-08-03 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 20,058 20,058 2,920 1.3941
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.